PHARMAENGINE, INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 94.3 TWD | +1.18% |
|
-1.15% | -10.62% |
| 05-02 | PharmaEngine, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 04-24 | PharmaEngine, Inc. Announces First Patient Dosed in Phase I Trial of PEP07 for Solid Tumors | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| PHARMAENGINE, INC. | Other Biotechnology & Medical Research | +1.18% | -1.15% | -10.62% | +0.96% | +4.66% | 414M |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- 4162 Stock
- Charts PharmaEngine, Inc.
- Comparison Chart
